{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:52:52Z","timestamp":1791193972631,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1038\/85115","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:48:04Z","timestamp":1027658884000},"page":"268-274","source":"Crossref","is-referenced-by-count":186,"title":["Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs"],"prefix":"10.1038","volume":"4","author":[{"given":"Michael","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavril W.","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnn0301_268_CR1","first-page":"6280","volume":"49","author":"RJ Bodnar","year":"1989","unstructured":"Bodnar, R. J. et al. Mediation of anorexia by human, recombinant Tumor Necrosis Factor thorugh a peipheral action in the rat. Cancer Res. 49, 6280\u20136284 (1989).","journal-title":"Cancer Res."},{"key":"BFnn0301_268_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0165-5728(90)90105-V","volume":"30","author":"JC Goodman","year":"1990","unstructured":"Goodman, J. C., Robertson, C. S., Grossman, R. G. & Narayan, R. K. Elevation of tumor necrosis factor in head injury. J. Neuroimmunol. 30, 213\u2013217 (1990).","journal-title":"J. Neuroimmunol."},{"key":"BFnn0301_268_CR3","first-page":"R518","volume":"270","author":"LI Romero","year":"1996","unstructured":"Romero, L. I., Kakucska, I., Lechan, R. M. & Reichlin, S. Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1\u03b2 in rats. Am. J. Physiol. 270, R518\u2013R524 (1996).","journal-title":"Am. J. Physiol."},{"key":"BFnn0301_268_CR4","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/0024-3205(87)90606-0","volume":"41","author":"WA Banks","year":"1987","unstructured":"Banks, W. A. & Kastin, A. J. Saturable transport of peptides across the blood\u2013brain barrier. Life Sci. 41, 1319\u20131338 (1987).","journal-title":"Life Sci."},{"key":"BFnn0301_268_CR5","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1002\/jnr.490350611","volume":"35","author":"WA Banks","year":"1993","unstructured":"Banks, W. A., Kastin, A. J. & Ehrensing, C. A. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1. J. Neurosci. Res. 35, 690\u2013695 (1993).","journal-title":"J. Neurosci. Res."},{"key":"BFnn0301_268_CR6","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0024-3205(96)00380-3","volume":"59","author":"WA Banks","year":"1996","unstructured":"Banks, W. A. & Kastin, A. J. Passage of peptides across the blood\u2013brain barrier: pathophysiological perspectives. Life Sci. 59, 1923\u20131943 (1996).","journal-title":"Life Sci."},{"key":"BFnn0301_268_CR7","doi-asserted-by":"publisher","first-page":"L47","DOI":"10.1016\/S0024-3205(99)00599-8","volume":"66","author":"CL Aquilante","year":"1999","unstructured":"Aquilante, C. L., Letrent, S. P., Pollack, G. M. & Brouwer, K. L. R. Increased brain P-glycoprotein in morphine tolerant rats. Life Sci. 66, L47\u2013L51 (1999).","journal-title":"Life Sci."},{"key":"BFnn0301_268_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1023\/A:1018892811980","volume":"16","author":"CP Chen","year":"1999","unstructured":"Chen, C. P. & Pollack, G. M. Enhanced antinociception of the model opioid peptide [d-Penicillamine2,5] enkephalin by P-glycoprotein modulation. Pharm. Res. 16, 296\u2013301 (1999).","journal-title":"Pharm. Res."},{"key":"BFnn0301_268_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1021\/js980410+","volume":"88","author":"RD Egleton","year":"1999","unstructured":"Egleton, R. D. & Davis, T. P. Transport of the \u03b4-opioid receptor agonist [d-penicillamine2,5] enkephalin across the blood\u2013brain barrier involves transcytosis. J. Pharm. Sci. 88, 392\u2013397 (1999).","journal-title":"J. Pharm. Sci."},{"key":"BFnn0301_268_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/sj.bjp.0702497","volume":"127","author":"JW Jonker","year":"1999","unstructured":"Jonker, J. W. et al. Role of blood\u2013brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug. Br. J. Pharmacol. 127, 43\u201350 (1999).","journal-title":"Br. J. Pharmacol."},{"key":"BFnn0301_268_CR11","first-page":"827","volume":"27","author":"SP Letrent","year":"1999","unstructured":"Letrent, S. P., Pollack, G. M., Brouwer, K. R. & Brouwer, K. L. R. Effects of a potent and specific P-glycoprotein inhibitor on the blood\u2013brain barrier distribution and antinociceptive effect of morphine in the rat. Drug Metab. Dispos. 27, 827\u2013834 (1999).","journal-title":"Drug Metab. Dispos."},{"key":"BFnn0301_268_CR12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"A Schinkel","year":"1994","unstructured":"Schinkel, A. H.et al. Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood\u2013brain barrier and to increased sensitivity to drugs. Cell 77, 491\u2013502 (1994).","journal-title":"Cell"},{"key":"BFnn0301_268_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/sj.bjp.0702804","volume":"128","author":"RJ Xie","year":"1999","unstructured":"Xie, R. J., Hammarlund-Udenaes, M., De Boer, A. G. & De Lange, E. C. M. The role of P-glycoprotein in blood\u2013brain barrier transport of morphine: transcortical microdialysis studies in mdr1a (\u2212\/\u2212) and mdr1a (+\/+)mice. Br. J. Pharmacol. 128, 563\u2013568 (1999).","journal-title":"Br. J. Pharmacol."},{"key":"BFnn0301_268_CR14","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1073\/pnas.86.2.695","volume":"86","author":"C Cordon-Cardo","year":"1989","unstructured":"Cordon-Cardo, C. et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-barrier sites. Proc. Natl. Acad. Sci. USA 86, 695\u2013698 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn0301_268_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/bj3260539","volume":"326","author":"E Beaulieu","year":"1997","unstructured":"Beaulieu, E., Demeule, M., Ghitescu, L. & Beliveau, R. P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochemistry 326, 539\u2013544 (1997).","journal-title":"Biochemistry"},{"key":"BFnn0301_268_CR16","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1172\/JCI118214","volume":"96","author":"AH Schinkel","year":"1995","unstructured":"Schinkel, A. H., Wagenarr, E., Van, D. L., Mol, C. A. & Borst, P. Absence of the mdrla P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, diagoxin and cyclosporin A. J. Clin. Invest. 96, 1698\u20131705 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnn0301_268_CR17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1097\/00000542-200005000-00030","volume":"92","author":"SJ Thompson","year":"2000","unstructured":"Thompson, S. J., Koszdin, K. & Bernards, C. M. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology 92, 1392\u20131399 (2000).","journal-title":"Anesthesiology"},{"key":"BFnn0301_268_CR18","first-page":"6969","volume":"52","author":"EJ Hegmann","year":"1992","unstructured":"Hegmann, E. J., Bauer, H. C. & Kerbel, R. S. Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res. 52, 6969\u20136975 (1992).","journal-title":"Cancer Res."},{"key":"BFnn0301_268_CR19","first-page":"545","volume":"287","author":"CP Chen","year":"1998","unstructured":"Chen, C. P. & Pollack, G. M. Altered disposition and antinociception of [d-Penicillamine2,5] enkephalin in mdr1a-gene-deficient mice. J. Pharmacol. Exp. Ther. 287, 545\u2013552 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnn0301_268_CR20","doi-asserted-by":"crossref","first-page":"20383","DOI":"10.1016\/S0021-9258(19)88713-6","volume":"267","author":"T Tatsuta","year":"1992","unstructured":"Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I. & Tsuruo, T. Functional involvement of P-glycoprotein in blood\u2013brain barrier. J. Biol. Chem. 267, 20383\u201320391 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFnn0301_268_CR21","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/0959-8049(95)00130-B","volume":"31A","author":"AH Schinkel","year":"1995","unstructured":"Schinkel, A. H. et al. Multidrug resistance and the role of P-glycoprotein knockout mice. Eur. J. Cancer 31A, 1295\u20131298 (1995).","journal-title":"Eur. J. Cancer"},{"key":"BFnn0301_268_CR22","doi-asserted-by":"publisher","first-page":"25617","DOI":"10.1172\/JCI118699","volume":"97","author":"AH Schinkel","year":"1996","unstructured":"Schinkel, A. H., Wagenaar, E., Mol, C. A. & Van Deemter, L. P-glycoprotein in the blood\u2013brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97, 25617\u201322524 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnn0301_268_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1046\/j.1471-4159.1998.71020705.x","volume":"71","author":"A Regina","year":"1998","unstructured":"Regina, A. et al. Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J. Neurochem. 71, 705\u2013715 (1998).","journal-title":"J. Neurochem."},{"key":"BFnn0301_268_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0896-6273(94)90333-6","volume":"12","author":"KM Standifer","year":"1994","unstructured":"Standifer, K. M., Chien, C.-C., Wahlestedt, C., Brown, G. P. & Pasternak, G. W. Selective loss of \u03b4 opioid analgesia and binding by antisense oligodeoxynucleotides to a \u03b4 opioid receptor. Neuron 12, 805\u2013810 (1994).","journal-title":"Neuron"},{"key":"BFnn0301_268_CR25","first-page":"1180","volume":"47","author":"Y-X Pan","year":"1995","unstructured":"Pan, Y.-X. et al. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor. Mol. Pharmacol. 47, 1180\u20131188 (1995).","journal-title":"Mol. Pharmacol."},{"key":"BFnn0301_268_CR26","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1046\/j.1471-4159.1995.65051981.x","volume":"65","author":"KM Standifer","year":"1995","unstructured":"Standifer, K. M. et al. Antisense oligodeoxynucleotides to the cloned \u03b4 receptor, DOR-1: uptake, stability and regulation of gene expression. J. Neurochem. 65, 1981\u20131987 (1995).","journal-title":"J. Neurochem."},{"key":"BFnn0301_268_CR27","first-page":"293","volume":"50","author":"KM Standifer","year":"1996","unstructured":"Standifer, K. M., Rossi, G. C. & Pasternak, G. W. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G-protein \u03b1 subunits. Mol. Pharmacol. 50, 293\u2013298 (1996).","journal-title":"Mol. Pharmacol."},{"key":"BFnn0301_268_CR28","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.1073\/pnas.94.15.8220","volume":"94","author":"YA Kolesnikov","year":"1997","unstructured":"Kolesnikov, Y. A. et al. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: Evidence for opposing NO actions on morphine analgesia and tolerance. Proc. Natl. Acad. Sci. USA 94, 8220\u20138225 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn0301_268_CR29","first-page":"3073","volume":"18","author":"ZQ Gao","year":"1998","unstructured":"Gao, Z. Q., Gao, Z. P., Fields, J. Z. & Boman, B. M. Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells. Anticancer Res. 18, 3073\u20133076 (1998).","journal-title":"Anticancer Res."},{"key":"BFnn0301_268_CR30","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood.V91.9.3163","volume":"91","author":"S Motomura","year":"1998","unstructured":"Motomura S. et al. Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene (mdr1) antisense oligonucleotides. Blood 91, 3163\u20133171 (1998).","journal-title":"Blood"},{"key":"BFnn0301_268_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1469-7793.1998.033bi.x","volume":"511","author":"LW Wang","year":"1998","unstructured":"Wang, L. W., Chen, L. X., Walker, V. & Jacob, T. J. C. Antisense to MDR1 mRNA reduces P-glycoprotein expression, swelling-activated Cl\u2212 current and volume regulation in bovine ciliary epithelial cells. J. Physiol. (Lond.) 511, 33\u201344 (1998).","journal-title":"J. Physiol. (Lond.)"},{"key":"BFnn0301_268_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev.ge.29.120195.003135","volume":"29","author":"MM Gottesman","year":"1995","unstructured":"Gottesman, M. M., Hrcyna, C. A., Schoenlein, P. V., Germann, U. A. & Pastan, I. Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29, 607\u2013649 (1995).","journal-title":"Annu. Rev. Genet."},{"key":"BFnn0301_268_CR33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4615-3794-6_9","volume-title":"Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells","author":"IB Roninson","year":"1991","unstructured":"Roninson, I. B. in Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells Ch. p (ed. Roninson, I. B.) 189\u2013211 Plenum, New York, 1991)."},{"key":"BFnn0301_268_CR34","first-page":"247","volume":"290","author":"Y Kolesnikov","year":"1999","unstructured":"Kolesnikov, Y. & Pasternak, G. W. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-d-aspartate antagonist. J. Pharmacol. Exp. Ther. 290, 247\u2013252 (1999).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnn0301_268_CR35","first-page":"502","volume":"279","author":"YA Kolesnikov","year":"1996","unstructured":"Kolesnikov, Y. A., Jain, S., Wilson, R. & Pasternak, G. W. Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance. J. Pharmacol. Exp. Ther. 279, 502\u2013506 (1996).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnn0301_268_CR36","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1046\/j.1471-4159.1997.68031278.x","volume":"68","author":"WM Pardridge","year":"1997","unstructured":"Pardridge, W. M., Golden, P. L., Kang, Y. S. & Bickel, U. Brain microvascular and astrocyte localization of P-glycoprotein. J. Neurochem. 68, 1278\u20131285 (1997).","journal-title":"J. Neurochem."},{"key":"BFnn0301_268_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0006-8993(84)91078-3","volume":"308","author":"SC Roerig","year":"1984","unstructured":"Roerig, S. C., O'Brien, S. M., Fujimoto, J. A. & Wilcox, G. L. Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites. Brain Res. 308, 360\u2013363 (1984).","journal-title":"Brain Res."},{"key":"BFnn0301_268_CR38","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1006\/bbrc.1996.5867","volume":"230","author":"JP Mathis","year":"1997","unstructured":"Mathis, J. P. et al. Biochemical evidence for orphanin FQ\/nociceptin receptor heterogeneity in mouse brain. Biochem. Biophys. Res. Commun. 230, 462\u2013465 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnn0301_268_CR39","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-5793(96)01023-X","volume":"395","author":"Y-X Pan","year":"1996","unstructured":"Pan, Y.-X. et al. Dissociation of affinity and efficacy in KOR-3 chimeras. FEBS Lett. 395, 207\u2013210 (1996).","journal-title":"FEBS Lett."},{"key":"BFnn0301_268_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0006-8993(94)91155-X","volume":"665","author":"GC Rossi","year":"1994","unstructured":"Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. \u03bc and \u03b4 opioid synergy between the periaqueductal gray and the rostro\u2013ventral medulla. Brain Res. 665, 85\u201393 (1994).","journal-title":"Brain Res."},{"key":"BFnn0301_268_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0006-8993(93)90075-X","volume":"624","author":"GC Rossi","year":"1993","unstructured":"Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. Synergistic brainstem interactions for morphine analgesia. Brain Res. 624, 171\u2013180 (1993).","journal-title":"Brain Res."},{"key":"BFnn0301_268_CR42","first-page":"149","volume":"232","author":"GSF Ling","year":"1985","unstructured":"Ling, G. S. F., Spiegel, K., Lockhart, S. H. & Pasternak, G. W. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms. J. Pharmacol. Exp. Ther. 232, 149\u2013155 (1985).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnn0301_268_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0014-2999(83)90203-0","volume":"86","author":"GSF Ling","year":"1983","unstructured":"Ling, G. S. F., Spiegel, K., Nishimura, S. & Pasternak, G. W. Dissociation of morphine's analgesic and respiratory depressant actions. Eur. J. Pharmacol. 86, 487\u2013488 (1983).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnn0301_268_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0167-0115(94)90468-5","volume":"54","author":"Y-X Pan","year":"1994","unstructured":"Pan, Y.-X., Cheng, J., Xu, J. & Pasternak, G. W. Cloning, expression and classification of a kappa3-related opioid receptor using antisense oligodeoxynucleotides. Regul. Pept. 54, 217\u2013218 (1994).","journal-title":"Regul. Pept."},{"key":"BFnn0301_268_CR45","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0306-4522(97)00096-1","volume":"80","author":"DS Rohde","year":"1997","unstructured":"Rohde, D. S., McKay, W. R., Chang, D. S., Abbadie, C. & Basbaum, A. I. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine. Neuroscience 80, 599\u2013612 (1997).","journal-title":"Neuroscience"},{"key":"BFnn0301_268_CR46","first-page":"858","volume":"282","author":"G Rossi","year":"1997","unstructured":"Rossi, G., Leventhal, L., Bolan, E. A. & Pasternak, G. W. Pharmacological characterization of orphanin FQ\/nociceptin and its fragments. J. Pharmacol. Exp. Ther. 282, 858\u2013865 (1997).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnn0301_268_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-3940(96)12976-1","volume":"216","author":"GC Rossi","year":"1996","unstructured":"Rossi, G. C., Brown, G. P., Leventhal, L., Yang, K. & Pasternak, G. W. Novel receptor mechanisms for heroin and morphine-6\u03b2-glucuronide analgesia. Neurosci. Lett. 216, 1\u20134 (1996).","journal-title":"Neurosci. Lett."},{"key":"BFnn0301_268_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0304-3940(97)13414-0","volume":"223","author":"MA King","year":"1997","unstructured":"King, M. A., Rossi, G. C., Chang, A. H., Williams, L. & Pasternak, G. W. Spinal analgesic activity of orphanin FQ\/nociceptin and its fragments. Neurosci. Lett. 223, 113\u2013116 (1997).","journal-title":"Neurosci. Lett."},{"key":"BFnn0301_268_CR49","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00318-0","volume":"374","author":"YA Kolesnikov","year":"1999","unstructured":"Kolesnikov, Y. A. & Pasternak, G. W. Peripheral blockade of topical morphine tolerance by ketamine. Eur. J. Pharmacol. 374, R1\u2013R2 (1999).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnn0301_268_CR50","volume-title":"Manual of Pharmacological Calculations with Computer Programs","author":"RJ Tallarida","year":"1987","unstructured":"Tallarida, R. J. & Murray, R. B. Manual of Pharmacological Calculations with Computer Programs (Springer, New York, 1987)."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nn0301_268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn0301_268","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn0301_268.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:36:55Z","timestamp":1684438615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nn0301_268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["BFnn0301_268"],"URL":"https:\/\/doi.org\/10.1038\/85115","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}